oral semaglutide compound | Starts at $249/mo FDA alerts health care providers,

Initially requiring twice-daily dosing, they have evolved to once-weekly, and oral formulations now exist

That baseline gives everyone a clear point of comparison later

Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease

Anjum NA, Umar S, Chan M-T

Being vigilant about any early signs of skin irritation and addressing them promptly can also help in prevention

Clinical Update 6/21/2022 Best Form of Carnitine